Prostatectomy Clinical Trials

Clinical trials related to Prostatectomy Procedure

Prostate-Specific Membrane Antigen (PSMA) Guided Approach for bIoCHEmical Relapse After Prostatectomy- A Prospective Observational Study-PSICHE

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This observational study was designed to evaluate progression free survival after PSMA-PET/CT based salvage approach for patients affected by biochemical relapse after radical prostatectomy.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:

• Signed informed consent

• Age \>18

• Patient suitable for 68Ga-PSMA PET/CT re-staging according to clinical practice (Previous radical prostatectomy with histological result of Prostate adenocarcinoma +/- postoperative prostate bed radiotherapy (adjuvant or salvage setting), with a biochemical relapse defined as a PSA \> 0.2 and \<1

Locations
Other Locations
Italy
AOU Careggi Radiation Oncology Unit
RECRUITING
Florence
Contact Information
Primary
Lorenzo Livi, Prof.
lorenzo.livi@unifi.it
+390557947264
Time Frame
Start Date: 2021-01-19
Estimated Completion Date: 2027-01-19
Participants
Target number of participants: 180
Treatments
1
Patients affected by biochemical relapse after radical prostatectomy undergoing staging PSMA-PET/CT and baseline blood sample for miRNA panel assessment.
Related Therapeutic Areas
Sponsors
Leads: Azienda Ospedaliero-Universitaria Careggi

This content was sourced from clinicaltrials.gov